TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nobel Biocare AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 50,646 | 48,122 | 35,783 |
Financial expenses | 2,569 | 1,645 | 445 |
Earnings before taxes | 3,067 | 1,222 | 442 |
EBITDA | 9,076 | 5,397 | 3,103 |
Total assets | 127,565 | 227,564 | 0 |
Current assets | 34,517 | 125,570 | 78,007 |
Current liabilities | 19,110 | 112,133 | 60,860 |
Equity capital | 107,253 | 114,116 | 115,219 |
- share capital | 28,503 | 31,015 | 31,600 |
Employees (average) | 364 | 350 | 296 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 84.1% | 50.1% | |
Turnover per employee | 139 | 137 | 121 |
Profit as a percentage of turnover | 6.1% | 2.5% | 1.2% |
Return on assets (ROA) | 4.4% | 1.3% | |
Current ratio | 180.6% | 112.0% | 128.2% |
Return on equity (ROE) | 2.9% | 1.1% | 0.4% |
Change turnover | 6,422 | 13,002 | -3,284 |
Change turnover % | 15% | 37% | -8% |
Chg. No. of employees | 14 | 54 | 3 |
Chg. No. of employees % | 4% | 18% | 1% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.